Vilitra-40 is a medication used in the treatment of erectile dysfunction (ED) in men. ED occurs when a man is unable to achieve or maintain an erection during sexual activity. Vilitra-40 works by relaxing the blood vessels in the penis, allowing for increased blood flow and thus, enabling an erection to occur.
The active ingredient in Vilitra-40 is Vardenafil, which is a type of phosphodiesterase type 5 (PDE5) inhibitor. PDE5 inhibitors are a class of drugs used to treat ED by blocking the action of PDE5 enzymes in the body, which leads to higher levels of cyclic guanosine monophosphate (cGMP) – a molecule that promotes smooth muscle relaxation and increases blood flow to the penis.
Vilitra-40 has an active half-life of 5-7 hours, meaning it stays in the body for a relatively short period of time. The recommended dosage for men is 20-40 mg per day, and it is usually taken orally about an hour before sexual activity. However, the dosage may vary depending on individual needs and response to treatment.
One of the advantages of Vilitra-40 is that it does not commonly cause acne or water retention. However, it is possible to experience water retention as a side effect of using the medication. Vilitra-40 does not typically cause hepatotoxicity (liver damage) or aromatization (conversion of testosterone to estrogen) either.
Vilitra-40 is available in the form of 10 pills, each containing 40 mg of the active substance, Vardenafil. It is manufactured by Centurion Laboratories, a leading pharmaceutical company that is based in India.
In conclusion, Vilitra-40 is a PDE5 inhibitor medication used to treat erectile dysfunction in men. It has an active half-life of 5-7 hours and is available in the form of 10 pills, each containing 40 mg of Vardenafil. It is important to consult a healthcare professional before using this medication as it may interact with other medications or have adverse effects in some individuals.
Chemical name: 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Formula: C23H32N6O4S
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
Reviews
There are no reviews yet.